Epitranscriptomic Mechanisms of Androgen Signalling and Prostate Cancer

Given the need for novel approaches to treat PCa (prostate cancer), there is significant interest in new therapies that target m6A that modulate androgen receptor expression and androgen signaling. This review critically summarizes the potential benefit of such epitranscriptomic therapies for PCa patients.